Fortrea's Upcoming Financial Results Conference Call
On November 8, 2024, Fortrea, a prominent name in contract research organizations (CRO), will unveil its third quarter financial results before the market opens. This strategic move comes as the company continues to thrive in the competitive life sciences sector, aiming to bring innovative solutions to biopharmaceutical and biotechnology industries.
Details of the Earnings Call
To engage in the earnings call, interested participants are encouraged to register ahead of time through the Fortrea Investor Relations website. The conference will commence at 8:00 am ET, giving stakeholders a timely opportunity to gain insights into the company’s performance and future strategies. It’s advisable to join the call at least 10 minutes early to ensure a smooth experience.
Accessing the Conference Call
The call can also be accessed via an earnings webcast, which will be made available for those who cannot attend live. Following the call, a replay will be posted, allowing stakeholders to catch up on what they may have missed. This flexibility ensures that all interested parties can remain informed about Fortrea's financial health and strategic direction.
About Fortrea: Leading Clinical Development Solutions
Fortrea has established itself as a leader in clinical development solutions across the life sciences landscape. The company partners with a variety of organizations—ranging from biotech startups to large pharmaceutical firms. Fortrea specializes in managing clinical trials from phase I to IV, and its expertise covers a diverse array of therapeutic areas. With over 30 years of industry experience, the team is committed to accelerating health innovations and delivering life-changing therapies to patients.
Fortrea's Commitment to Innovation
The combination of scientific knowledge and a robust global network of investigator sites positions Fortrea as a preferred partner in clinical development. The company’s innovative approach helps bridge the gap between laboratory advancements and tangible patient treatments. As Fortrea continues to grow, its focus remains on providing agile and customized solutions that meet the unique challenges faced by their clients.
Global Reach and Expertise
With approximately 100 countries under its belt, Fortrea’s diverse workforce brings together talent from all corners of the globe. This multicultural environment fosters creativity and collaboration, further enhancing the company’s ability to drive success in clinical trials. Fortrea’s dedication to operational excellence and client satisfaction is evident in every project.
Contact Information for Fortrea
Stakeholders interested in more information or specific inquiries can reach out through Fortrea's dedicated investor relations or media contacts. For investor-related questions, Hima Inguva is available at 877-495-0816 or via email. Sue Zaranek and Kate Dillon serve as media contacts, ready to provide assistance and information to the press.
Frequently Asked Questions
What is the date of Fortrea's third quarter financial results release?
Fortrea will release its third quarter financial results on November 8, 2024.
How can I participate in the earnings call?
Participants can register online at the Fortrea Investor Relations website to join the earnings call.
What time does the conference call start?
The conference call is scheduled to begin at 8:00 am ET on the release date.
Will the conference call be available for replay?
Yes, a replay of the conference call will be made available on the Fortrea Investor Relations website shortly after the live event.
What services does Fortrea provide?
Fortrea specializes in clinical trial management, clinical pharmacology, and various consulting services across all phases of clinical development.
